Free Trial

Solventum Q2 2024 Earnings Report

Solventum logo
$66.83 +0.03 (+0.04%)
(As of 12/20/2024 05:31 PM ET)

Solventum EPS Results

Actual EPS
$1.56
Consensus EPS
$1.46
Beat/Miss
Beat by +$0.10
One Year Ago EPS
N/A

Solventum Revenue Results

Actual Revenue
$2.08 billion
Expected Revenue
$2.05 billion
Beat/Miss
Beat by +$32.10 million
YoY Revenue Growth
+0.20%

Solventum Announcement Details

Quarter
Q2 2024
Time
After Market Closes

Conference Call Resources

The #1 Coin for November 2024 (Ad)

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

Solventum Earnings Headlines

Solventum Corp. stock rises Friday, still underperforms market
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
See More Solventum Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Solventum? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Solventum and other key companies, straight to your email.

About Solventum

Solventum (NYSE:SOLV), a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

View Solventum Profile

More Earnings Resources from MarketBeat

Upcoming Earnings